About

INVESTORS

Sofinnova Ventures

Sofinnova Ventures has over 40 years of experience building life science companies into market leaders. With $1.8 billion in committed capital, the firm applies capital and expertise to take companies from inception to exit. Sofinnova’s investment team of MDs, PhDs and seasoned executives has significant scientific, operational and strategic experience, and specializes in financing clinical therapeutics. Our team partners with entrepreneurs to build successful companies, advance medicine and address patients’ unmet medical needs.

Dauntless Pharmaceuticals Launches New Company Focused on Developing a Portfolio of Improved Therapeutics

Canaan Partners

Canaan Partners is an early stage venture capital firm that invests in entrepreneurs with visionary ideas. With $4.2 billion under management, a diversified fund and 190 exits to date, Canaan has invested in some of the world’s leading technology and health care companies over the past 30 years. Canaan’s focus areas include fin tech, enterprise/SaaS, marketplace, e-commerce, biopharma, digital health and medtech. To learn more about our people and our portfolio, please visit canaan.com.

PARTNERS

Aegis Therapeutics

Aegis Therapeutics LLC is a drug-delivery and drug-formulation technologies company commercializing its patented drug delivery and protein stabilization technologies through product specific licenses to leading pharmaceutical and biopharmaceutical companies.